Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

10.03
+0.36003.72%
Post-market: 10.030.00000.00%19:56 EST
Volume:1.15M
Turnover:11.45M
Market Cap:991.45M
PE:-12.30
High:10.05
Open:9.87
Low:9.70
Close:9.67
52wk High:18.90
52wk Low:6.66
Shares:98.85M
Float Shares:55.27M
Volume Ratio:0.87
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8154
EPS(LYR):0.0800
ROE:-45.92%
ROA:-19.22%
PB:6.71
PE(LYR):125.38

Loading ...

Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 29, 2025

Major Issues Report

Form 8-K - Current report
Aug 28, 2025

Major Issues Report

Form 8-K - Current report
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]